Inflammation is associated with sickness behavior symptoms in patients receiving chemotherapy. However, its impact on symptom burden (i.e., higher number of concurrent symptoms) requires evaluation. Study purposes were to evaluate for differentially perturbed immune and/or inflammatory pathways between outpatients receiving chemotherapy with Low (i.e., 0–8) versus High (i.e., 16–38) symptom burden and identify common immune and/or inflammatory pathways among symptom burden and single sickness behavior symptoms.
Cytokine–Cytokine Receptor Interaction and Endocytosis are Common Pathways for Symptom Burden and Sickness Behavior Symptoms in Oncology Patients Undergoing Chemotherapy
C. Harris,K. Kober,Joosun Shin,L. Morse,K. Oppegaard,Steven M. Paul,Marilyn J. Hammer,J. Levine,Yvette P. Conley,C. Miaskowski
Published 2025 in Cancer Medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Cancer Medicine
- Publication date
2025-11-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-96 of 96 references · Page 1 of 1
CITED BY
Showing 1-1 of 1 citing papers · Page 1 of 1